Practical Geriatrics ›› 2022, Vol. 36 ›› Issue (1): 2-5.doi: 10.3969/j.issn.1003-9198.2022.01.002
Previous Articles Next Articles
Received:
2021-10-18
Online:
2022-01-20
Published:
2022-01-25
CLC Number:
[1] International Diabetes Federation.IDF Diabetes Atlas[M]. 9th ed. Brussels: International Diabetes Federation, 2019. [2] TOMASOVA L, KONOPELSKI P, UFNAL M. Gut bacteria and hydrogen sulfide: the new old players in circulatory system homeostasis[J]. Molecules, 2016, 21(11):1558. [3] DAMBROVA M, LATKOVSKIS G, KUKA J, et al. Diabetes is associated with higher trimethylamine N-oxide plasma levels[J]. Exp Clin Endocrinol Diabetes,2016,124(4):251-256. [4] ZHUANG R, GE X, HAN L, et al. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: a systematic review and dose-response meta-analysis[J]. Obes Rev, 2019, 20(6):883-894. [5] SHAN Z, SUN T, HUANG H, et al. Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes[J]. Am J Clin Nutr, 2017,106(3):888-894. [6] MOFFA S, MEZZA T, CEFALO C M A, et al. The interplay between immune system and microbiota in diabetes[J]. Mediators Inflamm, 2019, 2019:9367404. [7] GAO X, LIU X, XU J, et al. Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet[J]. J Biosci Bioeng, 2014,118(4):476-481. [8] ZHOU H, SUN L, ZHANG S, et al. Evaluating the causal role of gut microbiota in type 1 diabetes and its possible pathogenic mechanisms[J]. Front Endocrinol: Lausanne, 2020, 11:125. [9] HASAIN Z, MOKHTAR N M, KAMARUDDIN N A, et al. Gut microbiota and gestational diabetes mellitus: a review of host-gut microbiota interactions and their therapeutic potential[J]. Front Cell Infect Microbiol, 2020, 10:188. [10] SHARMA S, TRIPATHI P. Gut microbiome and type 2 diabetes: where we are and where to go?[J]. J Nutr Biochem, 2019, 63:101-108. [11] HARMA M, LI Y, STOLL M L,et al. The epigenetic connection between the gut microbiome in obesity and diabetes[J]. Front Genet, 2019, 10:1329. [12] YU P, GONG X, MENG Q,et al. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: a systematic review and dose-response meta-analysis[J]. Obes Rev, 2019, 20(6):883-894. [13] ANDRAOS S, LANGE K, CLIFFORD S A, et al. Plasma trimethylamine N-oxide and its precursors: population epidemiology, parent-child concordance, and associations with reported dietary intake in 11- to 12-year-old children and their parents[J].Curr Dev Nutr, 2020, 4(7):nzaa103. [14] SCHUGAR R, SHIH D M, WARRIER M,et al. The TMAO-producing enzyme flavin-containing monooxy-genase 3 regulates obesity and the beiging of white adipose tissue[J]. Cell Rep, 2017, 19(12):2451-2461. [15] HEIANZA Y,SUN D,LI X, et al. Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial[J]. Gut, 2018, 68(2):263-270. [16] KASSELMAN L, VERNICE N A, DELEON J A. The gut microbiome and elevated cardiovascular risk in obesity snd autoimmunity[J]. Atherosclerosis, 2018, 271(2):203-213. [17] DÍAZ-RIZZOLO D A, KOSTOV B, LÓPEZ-SILES M,et al. Healthy dietary pattern and their corresponding gut microbiota profile are linked to a lower risk of type 2 diabetes, independent of the presence of obesity[J]. Clin Nutr, 2020, 39(2):524-532. [18] ASCHER S, REINHARDT C. The gut microbiota: an emerging risk factor for cardiovascular and cerebrovascular disease[J]. Eur J Immunol, 2018, 48(4):564-575. [19] SARAVANAN S. Trimethylamine oxide (TMAO): a new toxic kid on the block[J]. J Biomol Res Ther, 2018, 7(1):e159. [20] HAM B, HWANG H B, JUNG S H,et al. Distribution and diversity of ocular microbial communities in diabetic patients compared with healthy subjects[J]. Curr Eye Res, 2018, 43(3):314-324. [21] ST LEGER A J, CASPI R R. Visions of eye commensals: the known and the unknown about how the microbiome affects eye disease[J]. Bioessays, 2018, 40(11):e1800046. [22] BELI E, YAN Y, MOLDOVAN L,et al. Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice[J]. Diabetes, 2018, 67(9):1867-1879. [23] LUPACHYK S, WATCHO P, STAVNIICHUK R,et al. Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy[J]. Diabetes, 2013, 62(3):944-952. [24] YU Z L, ZHANG L Y, JIANG X M, et al. Effects of dietary choline, betaine, and L-carnitine on the generation of trimethylamine-N-oxide in healthy mice[J]. J Food Sci, 2020, 85(7):2207-2215. [25] ADACHI K, SUGIYAMA T, YAMAGUCHI Y, et al. Gut microbiota disorders cause type 2 diabetes mellitus and homeostatic disturbances in gut-related metabolism in Japanese subjects[J]. J Clin Biochem Nutr, 2019, 64(3):231-238. [26] HALUZÍK M, MRÁZ M. Intermittent fasting and prevention of diabetic retinopathy: where do we go from here?[J]. Diabetes, 2018, 67(9):1745-1747. [27] CHEN S, HENDERSON A, PETRIELLO M C, et al. Trimethylamine N-oxide binds and activates PERK to promote metabolic dysfunction[J]. Cell Metab, 2019, 30(6):1141-115. |
[1] | WANG Su, ZHAO Yijing, WEI Chenmin, CHEN Kun, CAO Wen, WANG Kun, YANG Yu. Correlation of triglyceride-glucose index with low-density lipoprotein subtypes in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(10): 1002-1006. |
[2] | GU Chonghuai, XIANG Xuejun, ZHENG Yuanxi, QIAO Rui, LIN Song. Efficacy of dapagliflozin in elderly patients undergoing coronary intervention with type 2 diabetes mellitus and ejection fraction reduced heart failure [J]. Practical Geriatrics, 2024, 38(10): 1025-1029. |
[3] | . [J]. Practical Geriatrics, 2024, 38(10): 1066-1069. |
[4] | LIU Qianhui, YAO Zijun, HE Yuli, XU Yunfan, WU Jun. Effects of HbA1c level on cardiac structure and function in elderly patients with type 2 diabetes mellitus and chronic heart failure [J]. Practical Geriatrics, 2024, 38(5): 491-437. |
[5] | LIU Tongjun, ZHAO Yajie, HU Jieling, HU Yang, LIANG Wei. Effect of glucose metabolic disorders on serum levels of activin-A [J]. Practical Geriatrics, 2024, 38(5): 495-437. |
[6] | . [J]. Practical Geriatrics, 2024, 38(5): 521-437. |
[7] | . [J]. Practical Geriatrics, 2024, 38(5): 529-437. |
[8] | TANG Yuan, DENG Shufang, HE Yongmei, DAI Yuxuan, LUO Jing. The status of health literacy and correlation with frailty in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(3): 255-259. |
[9] | DAI Ling-li, YU Yun. Association of estimated glomerular filtration rate with insulin resistance and β-cell function in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2023, 37(12): 1219-1223. |
[10] | FAN Ting-yong, YUAN Li, YANG Xiao-ling, CHEN Qian. Assessment effect of Caprini scale on venous thromboembolism in elderly patients with diabetes [J]. Practical Geriatrics, 2023, 37(12): 1233-1237. |
[11] | ZHANG He-cheng, WEI Su. Correlation of serum ferritin level with diabetic foot in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2023, 37(11): 1111-1114. |
[12] | HU Yan, WU Hai-di, WANG Xue-fei, LOU Qing-lin, YE Qing, GU Liu-bao, DAI Jing, SONG Xiao-bo. Correlation between diabetic foot risk score and urinary microalbumin/creatinine ratio in elderly patients with type 2 diabetes [J]. Practical Geriatrics, 2023, 37(11): 1134-1137. |
[13] | . [J]. Practical Geriatrics, 2023, 37(11): 1170-1175. |
[14] | ZHANG Lin-ying, MEI Qun-chao, ZHANG Wei-qi, HU Yi-lan. Application of resistance training combined with high milk protein nutrition in elderly patients with type 2 diabetes mellitus and sarcopenia [J]. Practical Geriatrics, 2023, 37(10): 995-999. |
[15] | . [J]. Practical Geriatrics, 2023, 37(10): 1064-1068. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|